|
市場調査レポート
商品コード
1261252
大腸内視鏡の世界市場規模、シェア、産業動向分析レポート用途別、エンドユーザー別、地域別展望と予測、2022年~2028年Global Colonoscope Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
大腸内視鏡の世界市場規模、シェア、産業動向分析レポート用途別、エンドユーザー別、地域別展望と予測、2022年~2028年 |
出版日: 2023年03月31日
発行: KBV Research
ページ情報: 英文 165 Pages
納期: 即納可能
|
大腸内視鏡市場規模は、予測期間中にCAGR6.8%で成長し、2028年には17億米ドルに達すると予測されます。
また、大腸内視鏡の治療能力の向上に伴い、大腸内視鏡手術の件数が急増すると予測されます。大腸内視鏡の市場は、低侵襲治療への志向の高まり、技術の進歩、大腸がんの蔓延によって牽引されています。しかし、大腸がんの原因は不明です。治療率の向上、世界の大腸がんの有病率の高さ、他の主要地域と比較して高い薬剤費などが、大腸がんの優位性に大きく寄与しています。
また、大腸内視鏡検査施設では、大腸内視鏡検査の利用率や実施量が高く、大腸内視鏡市場の拡大に寄与しています。大腸内視鏡、短ラン半径光学系、大腸内視鏡、複数のレンズを備えた消化器用機器、各種補助機器など、視認角度を高める機器が多く、市場成長に寄与しています。
COVID-19インパクト分析
パンデミック時には、選択的な外科手術が一時的に停止されました。さらに、COVID-19感染の危険を抑えるために、大腸内視鏡センターは、選択的な患者や準緊急の患者を延期したりキャンセルしたりしました。したがって、これらの変数から、大腸内視鏡市場はパンデミック時に中程度の悪影響を受けたことがわかります。しかし、ワクチン接種の普及により、大腸内視鏡産業は加速しています。また、ここ数カ月の間に、いくつかの組織が啓発キャンペーンを通じてがん検診を奨励するために協調的な試みを行っており、これが将来の市場需要を高めると予想されます。
市場成長要因
技術の進歩が著しい
HD大腸内視鏡の採用や、微妙な病変や小さなポリープの視認性に優れた画像処理技術のアップグレードは、大腸内視鏡検査における最も重要な技術的進歩のひとつです。HDはビデオディスプレイの画素数を増やし、より詳細で優れた画像を観客に提供することを可能にしました。最新の大腸内視鏡システムは、画角170度の高解像度HD大腸内視鏡を作ることができ、明るい画像、高い解像度、標準的な大腸内視鏡機器よりも30度広い視野を提供します。これらの要素を考慮すると、大腸内視鏡市場は予測期間を通じて拡大すると予測されます。
低侵襲手術への嗜好の高まり
大腸内視鏡検査は、ごく一部の組織を切除するだけで、がんの初期症状を発見し、より危険な段階への進行を防ぐことができるスクリーニング検査法です。大腸内視鏡検査は、患者さんの直腸に小さなカメラを挿入して、大腸の内壁を検査する診断方法です。この検査は短時間で終わり、痛みも全くないため、患者さんの命を救う可能性があります。この直接的な結果として、大腸内視鏡の市場は投影期間中に拡大すると予想されます。
市場の抑制要因
大腸内視鏡の処置に伴う高いリスク
ポリープ切除後電気凝固症候群は、腸の損傷を伴う極めて珍しい合併症です。胃の不快感や発熱につながることもあります。基礎疾患を持っている可能性が高いため、大腸内視鏡検査は、75歳以上の患者さんにとって合併症のリスクが高くなります。さらに、高齢の患者さんは、手術の準備がより困難になる可能性があります。その結果、脱水症状や電解質の不均衡を引き起こす可能性があります。これらの合併症は、患者がこれらの手術を受けることを躊躇させ、結果的に大腸内視鏡市場の成長を阻害する可能性があります。
アプリケーションの展望
用途に基づき、大腸内視鏡市場は大腸がん、潰瘍性大腸炎、クローンズ病、その他に区分されます。2021年、大腸内視鏡市場では、大腸がん分野が最も高い収益シェアを占めています。年齢、家族歴、座りがちなライフスタイル、アルコールの摂取、喫煙、不健康な生活行動は、大腸がん患者の憂慮すべき増加の重要な要因となっています。男女ともに、大腸がんは毎年3番目に多く発生するがんです。このような大腸がんの罹患率の増加は、市場の拡大につながると予想されています。
エンドユーザーの展望
エンドユーザー別では、大腸内視鏡市場は病院、外来手術センター、その他に二分されます。2021年の大腸内視鏡市場では、外来手術センター部門が顕著な収益シェアを記録しました。外来手術センターは、機能レベルを維持し、免疫学的反応を引き起こす可能性が低いため、その市場シェアは拡大すると予測されます。外来手術センターには必要な大腸内視鏡装置が設置されているため、そこで処置が可能です。また、外来手術施設では、処置のために宿泊する必要がないため、拡大に寄与しています。
地域別展望
地域別に見ると、大腸内視鏡市場は北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2021年に最大収益シェアを獲得して大腸内視鏡市場をリードしました。これは、同地域において、大腸がん&潰瘍性大腸炎などの慢性疾患の頻度が高いこと、市場参入企業が増加していること、利用可能なデバイスの種類が増加していることに起因しています。また、同地域における研究開発活動の活発化も市場開拓に寄与しています。
市場参入企業がとる主な戦略は買収です。カーディナルマトリックスに掲載された分析によると、大腸内視鏡市場ではメドトロニックPLCが先行しています。Stryker Corporation、Fujifilm Holdings Corporation、Olympus Corporationなどの企業は、大腸内視鏡市場における主要な革新的企業の一部です。
List of Figures
The Global Colonoscope Market size is expected to reach $1.7 billion by 2028, rising at a market growth of 6.8% CAGR during the forecast period.
The colonoscopy is the primary instrument used in basic colonoscopy. In circumstances where cecal intubation is problematic due to significant colonic stricture and curvature, this instrument has a longer length and diameter than a gastroscope. It includes a control section, an instrument channel with forceps, snare, injector, and clip device, a shaft to be introduced into the patient, the tip, a connecting section, and the line.
Certain variants additionally include a lever for varying stiffness. Colonoscopy requires the use of a colonoscope. It provides superior diagnostic specificity and sensitivity compared to barium enema, stool occult blood test, and computed tomography colonography. Colonoscopy permits accurate diagnosis and treatment without the need for invasive surgery. The increasing incidence of colorectal cancer is a major factor behind expanding the colonoscope market.
Moreover, as the therapeutic capacities of colonoscopes increase, the number of colonoscopy procedures is anticipated to skyrocket. The market for colonoscope is driven by the increasing inclination for minimally invasive treatments, technological advancements, and the prevalence of colorectal cancer. However, it is uncertain what causes colorectal cancer. Increased treatment rates, a high prevalence of colon cancer globally, and elevated drug expenses relative to other major regions are significant contributors to its predominance.
The utilization and amount of colonoscopy procedures performed at these facilities contributed to expanding the colonoscope market. Many instruments that enhance visibility angles, such as colonoscopes, short-run radius optics, colonoscopes, gastrointestinal devices with multiple lenses, and various auxiliary devices, contribute to market growth.
COVID-19 Impact Analysis
During the pandemic, elective surgical procedures were temporarily halted. Furthermore, to limit the danger of COVID-19 transmission, colonoscopy centers have postponed and canceled elective and semi-urgent patients. Hence, these variables indicate that the colonoscope market experienced a moderately negative influence during the pandemic. However, due to widespread vaccination, the colonoscope industry has accelerated. In addition, several organizations have made concerted attempts to encourage cancer screening through awareness campaigns over the past few months, which is anticipated to increase future market demand.
Market Growth Factors
Rising advancements in technologies
The adoption of HD colonoscopes and upgrades in imaging techniques for excellent visibility of subtle lesions and small polyps are among the most significant technological developments in the colonoscopy. HD has increased the number of pixels on the video display, allowing for greater detail and a superior image for the spectator. Modern colonoscopy systems are able to create high-resolution, HD colonoscopes with an angle of view of 170 degrees, providing brighter images, higher resolution, and a field of vision 30 degrees broader than standard colonoscopy instruments. In light of all these factors, the colonoscope market is predicted to expand throughout the forecast period.
Growing preference for minimally invasive procedures
The colonoscopy is a screening procedure that requires only a tiny portion of tissue removal and can detect any early signs of cancer, preventing it from progressing to a more dangerous stage. Colonoscopies are diagnostic procedures that include inspecting the lining of the large intestine by inserting a tiny camera into the rectum of the patient. The process takes only a short amount of time and is completely painless, and it has the potential to save the patient's life. As a direct consequence of this, the market for colonoscope is expected to expand during the time of the projection.
Market Restraining Factors
High risks involved during the colonoscopy procedures
Post-polypectomy electrocoagulation syndrome is an extremely unusual complication involving bowel damage. It might lead to stomach discomfort and fever. Due to the increased likelihood of underlying health concerns, colonoscopies provide a larger risk of complications for patients over 75. In addition, older patients may have a more difficult time preparing for the operation. It may result in dehydration or electrolyte imbalance. These complications may discourage patients from undergoing these operations, consequently hindering the growth of the colonoscope market.
Application Outlook
Based on application, the colonoscope market is segmented into colorectal cancer, ulcerative colitis, crohns disease and others. In 2021, the colorectal cancer segment held the highest revenue share in the colonoscope market. Age, family history, a sedentary lifestyle, consumption of alcohol, smoking, and unhealthy lifestyle behaviors are important contributors to the alarming increase in colorectal cancer cases. In both men and women, colorectal cancer is the third most prevalent cancer each year. This increased incidence of colorectal cancer is anticipated to expand the market.
End User Outlook
By end user, the colonoscope market is bifurcated into hospitals, ambulatory surgery centers and others. The ambulatory surgery centers segment recorded a remarkable revenue share in the colonoscope market in 2021. While ambulatory surgery centers offer to maintain a level of function and are less likely to provoke an immunological reaction, their market share is projected to expand. The procedure is possible there because ambulatory surgery centers are equipped with the necessary colonoscopy equipment. In addition, ambulatory surgery facilities do not require an overnight stay for procedures, contributing to their expansion.
Regional Outlook
Region wise, the colonoscope market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region led the colonoscope market by generating maximum revenue share in 2021. This is due to the high frequency of chronic diseases such as colon cancer & ulcerative colitis, the increasing number of market participants, and the rise in the variety of available devices in the region. In addition, the increase in research & development activities in the region contributes to expanding the market.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC is the forerunner in the Colonoscope Market. Companies such as Stryker Corporation, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in Colonoscope Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, SonoScape Medical Corp., Daichuan Medical (Shenzhen) Co., Ltd. (EndoFresh), and EndoMed Systems GmbH.
Recent Strategies Deployed in Colonoscope Market
Partnership, Collaboration and Agreement:
Jul-2022: Medtronic PLC entered into a partnership with MathWorks, an Israel-based medical technology company focused on cardiovascular disease. With this partnership, the company aimed to provide creative solutions and technologies from diagnosis to therapy.
Nov-2021: Medtronic PLC is partnering with Amazon.com to deliver pill-sized cameras to patients' doorsteps. For Medtronic, the goal is to offer a wider array of PillCams for 2021-Nov: Medtronic formed a partnership with Amazon, an American company that focuses on online advertising, e-commerce, digital streaming, cloud computing, and artificial intelligence. The partnership is aimed at delivering pillcams for patients in their homes for gastrointestinal care.
Product Launch and Product Expansion:
Nov-2021: Fujifilm revealed the ColoAssist PRO visualization system for colonoscopies. The new product allows clinicians to visualize the configuration of the endoscope throughout the procedure in real time by providing accurate navigation of the colonoscope inside the patient. The ColoAssist PRO reproduces a graphical model of the endoscope during the intubation.
Apr-2021: FUJIFILM Medical Systems U.S.A., Inc. unveiled G-EYE 700 Series Colonoscope. The new product would assist with visualization, stabilization, and control during routine examinations that would improve polyp detection when compared to standard colonoscopy. The launch of the G-EYE 700 Series line would expand the offering of the company's colonoscope portfolio.
Oct-2020: Olympus launched two colonoscopes, the PCF-H190T and the PCF-HQ190 in the market. The new PCF-H190T and the PCF-HQ190 offer extension to the existing capabilities for physicians for diagnosing and treating gastrointestinal tract disorders. Furthermore, the two new devices would improve physicians' access to and visualization of the anatomy.
Sep-2020: Olympus Corporation unveiled ENDO-AID, a platform powered by artificial intelligence (AI). The new AI platform includes the endoscopy application ENDO-AID CADe for the colon. The ENDO-AID provides a real-time display of automatically detected suspicious lesions. With this launch. the company aimed to enhance the standard of endoscopy around the world.
Acquisitions and Mergers:
Dec-2022: Olympus entered into an agreement to acquire Odin Vision, a British cloud-AI endoscopy start-up. The acquisition would enhance the company's capability to offer advanced AI-powered solutions and data-driven insights that can improve clinical and procedural workflows and potentially transform patient care.
Nov-2022: Boston Scientific Corporation signed an agreement to acquire Apollo Endosurgery, Inc, a medical technology company focused on the development of advanced therapeutic endoscopy devices. The acquisition is aimed to enter the endobariatric market and provide strong, continued growth of the company's business.
Aug-2022: Medtronic PLC completed the acquisition of Affera, Inc., a medical technology that delivers to address the cardiac arrhythmia market. Through this acquisition, the company aimed to expand its cardiac ablation portfolio that encompasses a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.
Nov-2020: Stryker Corporation took over Wright Medical Group N.V., a medical device company that focuses on extremities and biologics. The acquisition enables the company to enhance its market position globally in the trauma and extremities field. Additionally, the company aimed to grow the business of both companies by providing solutions that improve patient outcomes.
Aug-2020: Olympus Corporation came into an agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. The acquisition showcases the company's commitment for developing advanced colonoscopy tools and its offering in gastrointestinal therapeutic devices. Moreover, with this acquisition, the company aimed to improve the early detection and treatment of colorectal cancer (CRC).
Trials and Approvals:
Nov-2021: Medtronic PLC received approval for its PillCam™ Small Bowel 3 system from U.S. Food and Drug Administration for remote endoscopy procedures. PillCam SB3 system combines Medtronic's PillCam technology with Amazon logistics which offers a convenient option for a contactless procedure and helps ensure that patients can access care in a timely manner.
May-2021: EndoFresh received approval from FDA for EndoFresh Disposable Digestive Endoscopy System. The new product features an all-in-one design with a camera system, disposable upper GI endoscope, and disposable colonoscope. The product would enable the company to allow physicians to visualize, diagnose and operate gastrointestinal endoscopy.
Apr-2021: Medtronic PLC received de novo clearance from U.S. Food and Drug Administration for its GI Genius™ intelligent endoscopy module. The GI Genius module uses artificial intelligence (AI) to identify colorectal polyps. With the addition of AI in the GI Genius intelligent endoscopy module, the launch is aimed at improving colonoscopies and polyp detection and reducing variability in patient outcomes.
Market Segments covered in the Report:
By Application
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research